GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Dow, S&P, and Nasdaq Finished Higher After a Choppy Trading Session
Viking Falls Despite Positive Mid-stage Data for Liver Drug
Eli Lilly Wins Favorable Terms for Obesity Drug Use in U.K.
Raymond James Reiterates Strong Buy on Viking Therapeutics
Raymond James analyst Steven Seedhouse reiterates Viking Therapeutics (NASDAQ:VKTX) with a Strong Buy.
Pfizer Data for Breast Cancer Therapy Sends Olema Higher
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
On Friday, Pfizer Inc (NYSE:PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ:MRNA) and Merck & Co (NYSE: